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Specialized dendritic cells (DC) 1 have been identified in lymphoid organs of mouse 
and  rat  (1-3).  In  all  tissues,  the  frequency  of  DC  is  <1%  of  nucleated  cells,  as 
confirmed using a  monoclonal antibody (Ab) specific for mouse DC  (4). Methods for 
enriching DC  are available (2,  3,  5).  As a  result, several distinctive functions of DC 
have been established. DC are potent stimulators of mixed leukocyte reactions (MLR) 
(3,  6-8)  and  accessory cells for several immune  responses  (2,  9-11).  Recently, it has 
been  shown  that  selective  elimination  of DC  with  monoclonal  cytotoxic  Ab  and 
complement  ablates  MLR-stimulating  capacity  and  accessory  function  in  mouse 
spleen and spleen-adherent cells (12). The study of immune responses in man requires 
that the equivalent of the rodent DC be identified. 
We have chosen peripheral blood mononuclear cells (PBMC)  to begin the charac- 
terization of human  DC  for several reasons.  Large numbers  of blood leukocytes are 
readily obtained from blood-banking facilities, making it possible to enrich for a trace 
cell type like the DC.  If the functional data on rodents are applicable to man, then 
DC  should be present in PBMC,  which are active MLR  stimulators and proliferate 
when  modified by oxidizing agents.  One  would also predict that  some stage of the 
DC lineage would be present in the circulation, because DC are bone marrow-derived 
and undergo rapid turnover in mouse spleen (13). 
We show here that 0.1-0.5% of human  PBMC  have the same cytologic features as 
rodent DC. Enriched (20-60%)  populations of DC can be obtained with an approach 
modeled after the techniques  used  to purify mouse  DC.  Human  DC  are Ia positive 
and lack surface Ig, Fc receptors, the receptor for sheep erythrocytes, and several new 
lymphocyte and  monocyte  antigens  defined by  monoclonal  Ab.  Functional studies 
indicate that human  DC are  10-30 times more active than other leukocytes as MLR 
stimulators and as accessory cells for oxidative mitogenesis. 
Materials  and  Methods 
Culture Media and Serum. Cells were cultured in RPMI 1640 (Gibco Laboratories, Grand Island 
Biological Co., Grand Island, NY) supplemented with  1 mM gtutamine (Gibco Laboratories), 
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5 ×  10  -5 M  2-mercaptoethanol (Eastman Kodak, Rochester, NY), 100 U/ml penicillin, 20/lg/ 
ml gentamycin (Schering Corp., Kenilworth, N  J), and 5-10% serum. Fetal calf serum  (FCS; 
Flow Laboratories, Inc., Rockville, MD)  and newborn calf serum  (NBCS;  North American 
Biologicals, Miami, FL) were heat inactivated at 56°C for 30 min. Human serum was prepared 
from  1 U  of whole A + blood with no additives (Greater New York Blood Center, New York) 
after 4 h of clotting at 4°C, clarification by centrifugation, and storage at -70°C. 
Microscopy, Staining, and Cytochemist~y.  To examine cells in suspension by light microscopy, 
we centrifuged (400 g, 10 min, room temperature) 2 ×  105 cells onto 12-mm circular cover slips 
(Propper Manufacturing  Co.,  Long  Island City,  NY,  CGS,  distributed by  SGA Scientific, 
Bloomfield, N  J) coated with 75 ~g/ml poly-L-lysine (PLL, type VII, Sigma Chemical Co., St. 
Louis, MO), and incubated the cover slips for 20 min in RPMI  1640 to allow spreading. For 
phase contrast, cells were fixed with 1.25% glutaraldehyde in phosphate-buffered saline (PBS) 
for  15-30  rain.  To  make  lysosomes visible, cells were  exposed  to  acridine orange  (Allied 
Chemical Corp., Morristown, N  J), 2.5 ~g/ml culture medium at 37°C for 20 min, rinsed, and 
mounted in medium for immediate viewing with a  fluorescent microscope as described (14). 
Giemsa (10%  in  PBS,  Fisher Scientific Co.,  Pittsburgh, PA) staining was for  10-20  min  on 
cytocentrifuged specimens fixed  10 min  in absolute methanol.  Endogenous myeloperoxidase 
and  exogenous  horseradish  peroxidase  (type  II,  Sigma  Chemical  Co.)  were  visualized  in 
glutaraldehyde-fixed cells  exposed  to  0.4  mg/ml  3,3'diaminobenzidine  tetrahydrochloride 
(grade II, Sigma Chemical Co.)  and 0.1%  hydrogen peroxide (Mallinckrodt  Inc., St.  Louis, 
MO)  in 0.1  M  tris, pH  7.5,  for  10  rain at  20°C.  Nonspeeifie esterase staining  with alpha- 
naphthyl-butyrate (Sigma Chemical Co.) was exactly according to Li et al. (15). 
For transmission electron microscopy (EM), cells were fixed in a mixture of 1.25% glutaral- 
dehyde and 1% osmium tetroxide, stained en bloc with 0.25% uranyl acetate, and embedded in 
Epon as described (1). For scanning EM, cells on cover slips were fixed in 1.25% glutaraldehyde/ 
PBS,  washed,  and  stored  in  0.1  M  sucrose  in  0.1  osmium  cacodylate pH  7.4. Just  before 
examination, the  cover slips were  dehydrated in  ethanol,  transferred to  amyl acetate,  and 
critical-point dried  (Hitachi CTI, Tokyo, Japan)  in CO2.  Specimens were coated with gold 
(Polaron EM coating unit, E5000,  Polaron Instruments Inc., Doylestown, PA) and examined 
with a high resolution Hitachi scanning electron microscope (HHS/2R) at 20 kv, at a tilt angle 
of 30 °  (16). 
Endocytic Tests.  Soluble horseradish  peroxidase was  used  as  a  marker for pinocytosis as 
described (17).  Zymosan (Sigma Chemical Co.)  and latex (1.1 /ira, The Dow Chemical Co., 
Indianapolis, IN) were used to monitor phagoeytosis at particle/cell ratios of 20:1  and 200:1, 
respectively, for 1 h at 37°C. 
Indicator EoJthrocytes (E): Sheep erythroeytes (Scott Labs, FiskeviUe, RI) and bovine erythro- 
cytes (Rockland Inc., Gilbertsville, PA)  were obtained in alsevers and  used within  2 wk of 
arrival. For E rosetting, washed sheep E at 5% vol/vol in RPMI  1640 were treated with 0.02 U 
of Vibrio cholerae neuraminidase (En) (Calbiochem-Behring Corp., LaJolla, CA) per ml at 37°C 
for 45 min  and washed three times  (18);  alternatively, washed sheep E  were treated with 2 
aminoethylisothiouronium bromide (EAET) (Calbiochem-Behring Corp.) exactly by the method 
of Kaplan et al. (19).  Both En and EAET rosetted >80% of nonadherent PBMC, but <5% of B 
cell-enriched fractions. Sheep E coated with antibody (EA), IgM (EIgM), and IgM plus mouse 
complement (EIgMC) were prepared as described (5).  E-anti-human Ig were prepared using 
saline-washed bovine E  and chromic chloride coupling (20).  Rabbit anti-human F(ab)'2 IgG 
fragment serum was affinity purified on  human  IgG linked to cyanogen bromide-activated 
Sepharose  4B  (Pharmaeia  Fine Chemicals,  Div.  Pharmaeia  Inc.,  Piscataway,  NJ).  E  anti- 
human Ig bound >80% of B cell and <5% ofT cell-enriched fractions. Rosettes were formed in 
suspension (50 indicator cells per leucocyte were spun into a pellet) or on monolayers (1  ×  107 
to 2 ×  107 indicator cells were spun onto 12-mm cover slips in  13-mm glass cylinders). 
Immunofluorescence.  All reagents for immunofluorescence were diluted in 5% NBCS-RPMI 
1640-0.02%  sodium azide. Two heteroantisera were directly labeled with fluorochrome: rho- 
damine-coupled F(ab)'2 goat  anti-human  IgG,  IgM,  and  IgD  (N.  L.  Cappel Laboratories, 
Cochranville, PA), and rhodamine-coupled F(ab)'~ rabbit anti-human glycoprotein 29/33 (anti- 
HLA-DR  [21],  a  generous gift of Dr.  Shu  Man  Fu of The  Rockefeller University). A  large 
group  of mouse  monoclonal  Ab were  visualized by  indirect  immunofluoresence:  anti-HLA 1174  HUMAN  DENDRITIC  CELLS 
(61D2 [22], 1 t~g/ml, Bethesda Research Laboratories, Rockville, MD), anti-HLA-DR (59.5, 1 
~g/ml; and OKIal [23], 1/40 of ascites,  Ortho Pharmaceutical, Raritan, N  J);  antimonocyte 
(63D3,  10/.tg/ml; 61D3 [22], 1/Lg/ml BRL; OKMI [24], 50 #g/ml, Ortbo Pharmaceutical; and 
MI/70, rat anti-mouse "Mac-l" [25], culture supernatant kindly supplied by Dr. T. Springer, 
Harvard University, Boston, MA); anti-Fc receptor (clone 3G8 [26], 30 ~tg/ml, kindly provided 
by Dr. J.  Unkeless and Dr.  H.  Fleit of The Rockefeller University); anti-leukocyte common 
antigen (T29/33 [27], 1:300 dilution of ascites  kindly supplied by Dr. I. S. Trowbridge, Salk 
Institute, La Jolla, CA); anti-human  T cells (OKT 3 [28, 29], pan T cell Ag, 0.6/.tg/ml; OKT6 
[29, 30], common thymocyte and Langerhans cell Ag,  1.2/*g/ml; OKT8, I28, 29], suppressor 
cytotoxic Ag, 50 ~g/ml, Ortho Pharmaceutical). Cells on PLL~coated  cover slips were exposed 
to the primary Ab for 60 min at 4°C, rinsed in PBS, exposed to biotinylated horse anti-mouse 
IgG (Vector Laboratories, Burlingame, CA) at 50 btg/ml for 30 rain at 4°C, rinsed in PBS, and 
overlaid with fluoresceinated avidin (Vector Laboratories) at  100 ~g/ml for  30 min at 4°C, 
rinsed, fixed in 10% formalin/PBS for 20 min, mounted in glycerol, and viewed by epifluoresc- 
ence (Zeiss photomicroscope II, Carl Zeiss, Inc., New York). To detect intracellular Ig, ceils on 
PLL-coated cover slips were formalin fixed, rinsed in PBS, exposed  to absolute methanol for 30 
s, rinsed in PBS, and treated with rhodamine anti-human Ig, as above. This technique detects 
intracellular Ig in plasma cells from tonsil. 
Enriched Populations  of T  Cells,  Monocytes,  B  Cells,  and DC (Table It).  Our starting population 
was a concentrated leukocyte fraction (buffycoat) derived from 400 ml of blood by the Greater 
New York Blood Center. PBMC were recovered  on Ficoll 400/sodium diatrizoate (Histopaque 
1.077, Sigma Chemical Co,) with a yield after three washes of 4 X 108 to 10 X l0  s mononuclear 
cells per buffycoat. Leukocyte subpopulations  were identified by standard cytologic and surface 
markers as described in results. 
5  ×  107  PBMC were plated in 5%  FCS medium on  100-mm plastic tissue culture plates 
(Falcon 3003, Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, CA) for 1 h at 37°C. 
Nonadherent cells were removed with five rinses of RPMI 1640 and used as a source of T cells. 
The T  cells were purified on nylon wool according to Julius et al.  (31). 10 ×  107 to 20 ×  107 
nonadherent PBMC in 10% NBCS medium were  loaded onto 3 g of nylon wool  (Leukopak, 
Fenwal Lab, Division of Travenol, Deerfield, IL) in a 30-cc disposable plastic syringe, incubated 
at 37°C for 45 rain, eluted dropwise over 15 rain, and washed three times in RPMI 1640 before 
use. The population was >97% T  cells, <3% monocytes, and <1% DC. Alternatively, nonad- 
herent PBMC were separated into E rosette positive and negative fractions after rosetting with 
a  50:l  ratio of En to PBMC and centrifugation on Ficoll/diatrizoate (17). E, were lysed  in 
ammonium chloride and the  fractions washed  three  times before use.  The E + fraction was 
>90% T cells, <10% monocytes, and <1% DC. The E- or non-T cell fraction was <20% T celts, 
30-50% Ig-positive cells, 8-30% monocytes, and 2-10% DC. 
Adherent PBMC were incubated for  16 h at 37°C in 5% FCS medium. About one-half the 
cells  had  released from the plates  (released  once)  and were  reattached  in fresh  medium to 
another 100-ram plastic plate for 1 h. The populations that adhered after overnight culture, or 
after the readherence step, were highly enriched in monocytes (80-90%)  and had some small 
lymphocytes (5-15%)  and DC (1-6%).  Monocytes were eluted from the plates after treatment 
with  phosphate  saline supplemented with  10  mM  ethylenediaminetetraacetic acid  (Fisher 
Scientific Co.,  Pittsburgh, PA), pH  7.4, for  30  rain at  4°C, or were  dislodged by vigorous 
pipetting. 
Cells that did not readhere (released  twice) after overnight culture were used as a source of 
enriched B cells and DC. The population was either rosetted with E anti-human Ig (50:1 ratio 
ofE anti-Ig/PBMC;  4°C, 20 min) or floated directly in bovine plasma albumin (BPA; Armour 
Pharmaceutical, Chicago, IL). 2 ×  107 to 4 ×  10 7 cells (+/- rosettes) were resuspended in 4 ml 
BPA, d =  t.082, and overlaid with BPA at  1.047 (2  hal). The columns were centrifuged at 
10,000 g  for  15 min at 4°C, to provide low density (1.047:1.080)  interface and high density 
(pellet)  fractions that  were  harvested and washed  3 times in RPMI  1640. The low  density 
population could be additionally depleted of monocytes by a final adherence on plastic. The 
low  density fraction  (2  ×  106  to  5  ×  106  cells/buffycoat) contained 20-60%  DC,  10-25% 
monocytes, and the balance small cells. If the fractionation included E anti-Ig rosetting, <1'7c 
of the low density cells had surface Ig, even after 4 d of additional culture. Without rosetting, VAN VOORHIS,  HAIR,  STEINMAN, AND  KAPLAN 
TABLE I 
Enrichment Procedure  for Dendritic Cells in Human Blood 
1175 
Concentrated leukocyte fraction  Cell yield 
(percent of  Percent  DC 
(buffy coat)  starting) 
Granulocytes ~, 
erythrocytes 
Nonadherent PBMC ( 
E, rosetting 
or nylon wool 
T cell enriched 
Firmly adherent, 
monocyte enriched 
Readherent, 
monocyte enriched 
High density, released 2 ×  ( 
B cell enriched 
Readherent, released 2 X ( 
l  Ficoll-Diatrizoate 
PBMC 
Adherence 
Adherent PBMC 
Culture 
16 h 
Released 1 × 
I  Readhere 
Released 2 X 
Flotation 
in dense BPA; 
+/- rosetting 
E a-human Ig 
100  <1 
20  1-2 
11  2-4 
6  3-6 
Low density, released 2 x  0.8  10-30 
! 
Low de~nsity,  released 3 ×  0.5  20-60 
DC enriched 
20-40% of the low density population was Ig positive cells. The high density fraction was always 
>80% Ig positive cells with small numbers of monocytes (2-5%)  and DC  (1-4%).  DC in the 
high density fraction would not float if centrifuged in an additional BPA column. 
Functional Assays.  Functional assays were done in triplicate microtest wells with  1.5 ×  10  '~ 
responder T-enriched lymphocytes per flat-bottomed well (Costar, Data Packaging, Cambridge, 
MA) in 200 ~1 culture medium, or in round-bottomed wells (Linbro Chemical Co., Hamden, 
CT)  in  150/zl medium. A+  leukocytes and  10% A+  human serum were  used.  T  cells were 
prepared from nonadherent PBMC by En rosetting, or passage  over nylon wool, as described 
above. For MLR assays,  stimulator cells were  irradiated with 3,000  rad  (Cs  lay, Gamma cell 
1000, Atomic Energy of Canada, Ottawa, Canada). For oxidative mitogenesis, the accessory 
cells  were  irradiated, and the T  cells were  modified with  2  mM sodium periodate  (Sigma 
Chemical Co.)  in PBS for 30 rain at 0°C, followed  by washing. Proliferation by unmodified 
(not  periodate-treated)  controls was  <10%  of periodate-treated  samples.  Proliferation was 
measured with 1 ~Ci [3H]thymidine in 50/~l/well (Schwarz/Mann Div., Becton, Dickinson & 1176  HUMAN  DENDRITIC  CELLS 
Co., Orangeburg,  NY,  6 Ci/mM)  at  104-120  h  (MLR)  and 56-72  h  (periodate). Cells were 
harvested in a  multisample harvester, and the data displayed as mean counts per minute ___ 
standard deviation of the mean. 
Results 
A  small percentage  (1-2%)  of adherent  human  PBMC  had  similar morphologic 
features to the DC isolated from mouse lymphoid organs (1). These features included: 
irregular  shape,  abundant  phase-dense  granules  (mitochondria),  irregular  nucleus 
with small nucleoli, and a  prominent rim of heterochromatin. There were few surface 
ruffles,  pinocytic vesicles, or  lysosomes, organelles  that  were  abundant  in  adjacent 
monocytes  (Fig.  1 a).  We  first  devised  a  multistep  procedure  for  enriching  these 
"candidate" DC. This involved successive depletion ofT cells, monocytes, and B cells. 
We could then show that  the cytologic, surface, and  functional properties of human 
DC were similar to their counterparts in rodents. 
Enriched Preparations of Human DC.  The purification of human  DC was monitored 
by phase-contrast microscopy of specimens fixed in glutaraldehyde. At each stage of 
the protocol (Table I), samples were attached to PLL-coated cover slips and incubated 
at  37°C  to  allow cells to  spread.  DC  exhibited many  processes, mitochondria,  and 
irregular nuclei (Fig. 1 b, c). Monocytes spread circumferentially and had clear ruffles, 
pinocytic  vesicles,  lysosomes,  and  oval-  or  kidney-shaped  nuclei  (Fig.  1 d).  Small 
lymphocytes showed  little spreading  (Fig.  1 c),  except  in  the  case of B  cells, which 
Fro.  1.  Phase-contrast microscopy of glutaraldehyde-fixed, adherent mononuclear cells (× 1,080). 
(a) Fresh mononuclear cells adherent to glass. A DO is surrounded by four monocytes, which exhibit 
typical ruffles,  lysosomes, and  pinocytic  vesicles. (b,  c)  DO  from  DC-enriched  fractions,  after 
attachment and spreading on PLL-coated glass cover slips. Dendrites extend in several directions, 
and the cytoplasm is full of granules that are mitochondria. At the top of Fig 1 c is a typical small 
lymphocyte, which does not have processes  or ruffles when attached to PLL. (d) Monocytes adherent 
to PLL-coated  glass. The cells spread more actively than on non-PLL-coated  glass or plastic, and 
the characteristic ruffles and organelles are more readily visualized. VAN VOORHIS, HAIR, STEINMAN, AND KAPLAN  1177 
could form cell processes when attached to anti-Ig-coated erythrocytes. Subsequent 
studies with cell surface markers confirmed that these cytologic criteria were appro- 
priate for differentiating DC, monocytes, and lymphocytes (see below). 
DC enrichment required several steps and stimultaneously provided populations 
that were predominately monocytes, B cells, or T  cells (Table I). Mononuclear cells 
(<1%  DC)  were obtained from Ficoll-Diatrizoate columns and  attached  to plastic. 
The  adherent  population  contained  70-90%  monocytes,  5-15%  lymphocytes, and 
<5% DC. The nonadherent fraction contained most of the T  cells and small percent- 
ages of monocytes (<5%), B cells (5-10%), and DC (< 1-2%). The adherent population 
was cultured overnight and the once-released cells reattached to plastic. This provided 
an adherent fraction rich in monocytes and a  nonadherent  (twice-released) fraction 
containing B cells, most of the DC, and variable percentages (10-40%) of monocytes. 
The twice-released cells were then floated on dense BPA columns to obtain a  high 
density B lymphocyte fraction and a low density population enriched in DC. Further 
enrichment  of DC  could  be obtained  by depleting  B  cells  with  E  anti-Ig  and  by 
additional adherence to monocytes to plastic. 
This procedure reproducibly provided populations that were 20-60% DC, so that 
a > 100-fold enrichment over PBMC had been obtained. The principle contaminating 
cells were monocytes (10-20%) and small cells of uncertain type that lacked B and T 
lymphocyte markers. Attempts to further purify DC led to unacceptable losses.  We 
also analyzed specimens obtained from fresh venipuncture, rather than buffycoat. In 
10  samples  from  8  donors,  we  obtained  a  yield of low  density, once-released DC 
corresponding to 0.3 +  0.2% of total PBMC. 
Staining Techniques and Electron Microscopy.  DC-enriched fractions were compared 
with  other cell types using several cytologic techniques.  On  Giemsa stain,  the DC 
cytoplasm was  a  pale  blue-gray,  like  monocytes, and  lacked  azurophilic  granules. 
Both  DC  and  lymphocytes had  small  numbers  of lysosomes, detected by acridine 
orange  staining,  whereas  all  monocytes had  abundant  granular  staining.  DC  and 
lymphocytes were peroxidase negative, whereas >80-90% of monocytes had typical 
peroxidase-positive granules. Finally, DC and lymphocytes were esterase negative, or 
had weak staining in the perinuclear region, while >80% of monocytes were strongly 
positive. 
By  transmission  EM  (Fig.  2 a),  the  DC-enriched  fraction  contained  small  cells 
(-50%)  with  the  features of lymphocytes, a  minor  component  (<20%)  of typical 
monocytes with many lysosomes and surface ruffles, and cells  (25-40%)  resembling 
mouse DC  (Fig. 2 a). The nuclei of presumptive DC were irregular in shape, with a 
thick rim of heterochromatin and small nucleoli. The surface was irregular incontour 
but  lacked the  discrete microvilli and  ruffles seen on lymphocytes and  monocytes. 
Mitochondria were numerous, but rough endoplasmic reticulum, free polysomes and 
ribosomes,  and  lysosomes were scanty.  Multivesicular  bodies  and  chains  of small, 
smooth vesicles were noted. Birbeck granules, which are found in epidermal Langer- 
hans cells, were not detected in either DC- or monocyte-enriched fractions. 
By scanning EM (Fig. 2 b, c) 30% of the cells in the DC-enriched population had 
similar  features  to  adherent  mouse  DC.  When  attached  to  PLL,  the  smooth  DC 
surface  formed  many  dendrites  and  large  lamellipodia.  Monocytes  were  entirely 
different in appearance because they spread circumferentially and were covered with 
surface  folds  (Fig.  2 d).  We conclude that  the  DC  in  human  PBMC  have similar 1178  HUMAN  DENDRITIC  CELLS 
FIc.  2.  EM  of glutaraldehyde-  and  osmium-lxed mononuclear cells.  (a)  Transmission EM  of 
presumptive DC  fixed  in  suspension. Cells with  similar cytologic  features (see  text)  account  for 
about one-third of DC-enriehed fractions. ×  11,300.  (b, c)  Scanning EM of DC fixed 20 min after 
attachment  to  PLL-coated  cover  slips.  The  smooth surface  forms many dendrites  and/or  large 
lamellipodia. ×  5,900 and 6,300. (d) Scanning EM of monocytes fixed 20 min after attachment to 
PLL. The surface is covered with folds, and the cells spread circumferentially, x  1,900. VAN  VOORHIS,  HAIR,  STEINMAN,  AND  KAPLAN  1179 
cytologic  features  to  mouse  DC,  and  can  be  distinguished  from  monocytes  and 
lymphocytes. 
Endocytic  Capacity and  Rosette Assays.  DC  behaved  more  like  lymphocytes  than 
monocytes in standard endocytic tests. DC did not phagocytose zymosan particles or 
latex, although some sticking of latex to DC (one to three beads per cell) was evident. 
In contrast, monocytes actively phagocytosed both particles. DC pinocytosed little or 
no  horseradish  peroxidase  (HRP),  as  assessed  by diaminobenzidine cytochemistry, 
after exposure to 1 mg/ml of enzyme for 1-2 h. Although monocytes had endogenous 
peroxidase activity, addition of exogenous HRP for 1 h at 37°C resulted in dramati- 
cally increased granular peroxidase staining, due to active pinocytosis. 
DC  and  monocytes  were  also  compared  in  rosette  assays  with  appropriately 
modified erythrocytes (see  Materials and  Methods).  DC  failed to bind En,  EAET, E 
anti-human  Ig, EIgM, and EA.  However, 2-10 EIgMC bound to DC identified by 
cytologic criteria. Mouse spleen DC failed to bind EIgMC, as previously reported (5). 
Monocytes did not bind En, EEAT, and EIgM. 3-5 E anti-human Ig bound to 10-20% 
of monocytes. Large numbers of EA and EIgMC rosetted to monocytes. The EA were 
also phagocytosed. Thus, human DC have weak endocytic capacities, are Fc receptor, 
surface Ig, and sheep erythrocyte receptor negative, but express complement receptors. 
Cell  Surface Markers--Indirect  Immunofluorescence.  A  large  group  of Ab,  primarily 
monoclonals, were used to visualize surface antigens by immunofluorescence, usually 
with  sensitive  biotin-avidin  reagents  (Table  II).  All  cells  expressed  the  leukocyte- 
common antigen (clone T29/33) and HLA (clone 61D2). Most of the ceils in the DC- 
enriched fraction were strongly Ia positive using OKIa 1, anti-HLA-DR (clone 59.5), 
and an F(ab)'2 rabbit anti-GP 29/33  (20).  Ia was found on most B cells, 30-80% of 
TABLE  II 
Fluorescent Staining of Subpopulations of PBMC 
Antibody (antigen)  T  cell  Monocyte  B cell  DC 
enriched*  enriched:[:  enriched§  enriched [[ 
OKT3 (PAN T  cell antigen) 
OKM 1 (monocyte/null cell antigen) 
OKIal (HLA-DR antigen) 
T29/33  (Human leukocyte-common antigen) 
aIg (surface Ig) 
63D3 (monocyte antigen) 
OKT6 (Thymocyte-common antigen and 
Langerhans cell antigen) 
61D3 (monocyte antigen) 
MI/70 (mac-1; granulocyte, monoeyte antigen) 
%  %  %  % 
96  10  8  11 
5  91  5  10 
3  92  92  89 
100  100  100  100 
<1  2  85  <1 
1  87  ND¶  9 
<1  <1  <1  <1 
ND  96  ND  9 
ND  96  ND  10 
Data are representative of three or more experiments with each cell type and antibody, and are expressed 
as percent positive (fluorescent) of 200 or more total cells counted. Cell populations were prepared as in 
Table I and included: 
* Nylon wool-purified T  cells. Phase-contrast morphology: 98% lymphocytes, 2% monocytes, 1% DC. 
~: Firmly adherent cells. Phase-contrast morphology: 87% monocytes, l 1% lymphocytes, 1% DC. 
§ Released twice, high density cells. Phase-contrast morphology: 95%  lymphocytes, 4% monocytes, 1% 
DC. 
[I  Low density released three times, E  anti-human Ig-negative cells. Phase-contrast morphology: 37% 
DC, 10% monocytes, 53% small cells. 
¶ Not done. 1180  HUMAN DENDRITIC CELLS 
monocytes, and few T  cells. Several monocyte antigens  (clones 63D3, 61D3, OKM  1, 
and Mac-l, or M1/70)  were detected on all monocytes and few of the cells in the B- 
and r/'-enriched  fractions.  10-20%  of the  DC-enriched  population  stained  with  the 
monocyte Ab. This corresponded exactly to the percentage of monocytes enumerated 
by cytologic features on well-spread, glutaraldehyde-fixed specimens;  also, many of 
the positive cells in the fluorescent specimens showed cytologic features of monocytes. 
A  monoclonal  anti-Fc  receptor  reagent,  clone  3G8,  did  not  stain  cells  in  the  DC- 
enriched fraction, but it is known that this reagent stains neutrophils primarily, and 
relatively  few  monocytes  and  B  cells  (25).  All  B  cells  stained  for  surface  Ig,  but 
staining was rare in purified monocytes and DC fractions. Less than 2% of the latter 
stained for intracellular Ig as well. T  cell-enriched populations contained >95% OKT 
3-  (pan  T)  reactive cells,  whereas  DC,  monocytes, and  B  cells  had  ~10%  OKT  3 
positive cells. DC were also OKT 8 negative (not shown). OKT 6, a monoclonal that 
reacts with thymocytes and Langerhans cells, did not stain any PBMC. We conclude 
that  DC are HLA- and  HLA-DR-bearing leukocytes that  lack many of the known 
differentiation antigens of B cells, T  cells, and monocytes. 
DC in Culture.  In two experiments, enriched preparations of DC were maintained 
in culture for 4 d. The distinctive cytologic features of DC persisted, and the cells did 
not  acquire  surface  Ig.  B  cells  maintained  surface  Ig  in  culture,  and  monocytes 
retained  their cytologic features. Therefore, DC do not convert into lymphocytes or 
monocytes in vitro. 
Stimulation  of the Primary MLR.  DC-enriched  fractions were strong stimulators of 
both syngeneic and allogeneic primary MLR, and were at least 10 times more efficient 
than other cell populations on a per cell basis (Table III; each of the populations has 
been tested in three or more additional experiments with similar results to experiment 
2).  The potency of the DC-enriched fraction was not  reduced  after B cell depletion 
with E  anti-human Ig rosetting (Table III, experiment 2).  The use of BPA columns 
to enrich  DC was not  itself responsible for the activity of DC as MLR stimulators. 
That  is,  for  both  allogeneic  and  syngeneic  MLR,  the  total  stimulating  activity 
recovered from the  BPA  columns  was similar to  the  activity in  the  applied  tw:,ce- 
released cells (not shown). 
Other cell fractions were evaluated for MLR-stimulating activity. Contaminating 
DC in each fraction were enumerated by cytologic criteria. Monocyte fractions were 
at least  10 times less active than DC. Typically, the monocyte fractions contained  1- 
6% DC and 80-90%  monocytes, and the DC populations  had  25-40%  DC and  10- 
25%  monocytes.  Therefore,  stimulatory  capacity  correlated  with  Ia  +  DC  content, 
rather  than  content  of Ia  +  monocytes  (as  most  monocytes are  Ia  +,  e.g.,  Table II). 
Nonadherent, E rosette-negative or non-T cells were 10-30 times less active than DC- 
enriched  fractions  in  MLR  stimulation,  and  again,  small  numbers of DC  (2-10%) 
could be identified in this population. High density B cells, obtained from the twice- 
released population  (Table I) were consistently 30-50 times less active than enriched 
DC (Table III). However, increased stimulating capacity was noted when B cells were 
sedimented after E  anti-Ig rosetting of twice-released cells (Table III, experiment 2). 
This was not attributable to rosetting itself, because B cells that were first sedimented 
and  then  rosetted  were  not  stimulatory  (not  shown).  More  likely,  the  stimulating 
activity was due  to  DC  trapped  during  the  rosetting procedure,  and  in  fact,  1-3% 
nonrosetted  DC were observed in the B cell fractions.  Lastly, enriched- T  cells were VAN VOORHIS, HAIR, STEINMAN, AND KAPLAN  1181 
TABLE III 
Stimulating Capacity of Subpopulations of Mononuclear Cells  for the 1  ° Syngeneic (Syn) and Allogeneic (Allo) 
MLR 
Source 
of re- 
sponder 
T  cells 
Dose of irradiated stimulator cells 
105  3 ×  104  104  3 ×  10  a  l03 
Experiment  1 
DC enriched (without Ealg roset-  Syn  11,983 4- 605  7,119 4- 2,555  3,172 ±  664 
ting)  Allo  119,506 ±  4,663  105,350 4- 15,849  62,922 4-6,106  32,670 ±  1,243 
Mon~cyte enriched (firmly adhero  Syn  1,131 4- 630  2,034 ±  1,976  670 4- 800 
ent)  Allo  31,148 ±  226  44,232 ±  4,712  18,509 ±  3,431 
Monocyte enriched (readherent)  Syn  1,706 4- 425  762 ±  243  660 4- 359 
Allo  38,361 4- 1,038  29,937 4- 3,655  16,461  4- 706 
B  cell enriched  (high density  re-  Syn  219 4- 5  526 4- 584 
leased without  Ealg rosetting)  Allo  2,766 4- 1,143  2,765 4- 1,301  735 4- 353 
T  cell enriched (En ÷)  Syn  ND*  869 4- 522 
Allo  ND  l 1,682 4- 1,669 
Non-T ceils (En)  Syn  6,012 4- 5,413  2,755 ±  1,517 
Allo  36,331 ±  2,105  16,130 4- 2,149  4,378 4- 2,875  2,732 4- 782 
Experiment 2 
DC enriched (with Ealg rosetting)  Syn  11,621  4- 2,397  8,489 4- 983  5,858 4- 2,225  2,548 4- 1,688 
Allo  ND  35,511 4- 4,882  26,797 4- 3,999  18,322 4- 6,l 10 
DG enriched (without Ealg roset-  Syn  14,943 4- 363  7,403 4- 856  7,222 4- 2,668  1,620 4- 285 
ting)  Allo  112,435 4- 5,571  45,464 4- 2,787  32,161 4- 7,375  23,330 4- 6,648 
Monocyte enriched (firmly adher-  Syn  5,474 ±  412  1,562 ±  899  677 4- 325  458 ±  326 
ent)  Allo  42,893 4- 4,891  8,433 4- 461  3,324 4- 1,258  2,188 4- 740 
Monocyte enriched (readherent)  Syn  999 +  185  641 ±  402  422 ±  285  855 4- 627 
Allo  15,032 4- 1,496  2,943 4- 1,042  1,546 ±  348  1,514 4- 739 
B cell enriched (high density after  Syn  3,291 ±  1,088  1,981 4- 721  1,268 +  566  595 4- 33 I 
EaIg rosetting)  Allo  31,280 ±  4,371  19,684 4- 552  9,317 4- 2,058  5,008 4- 1,989 
B cell enriched (high density with-  Syn  1,130 4- 443  611 ±444  1,9174-1,159  1,1664-1,130 
out Ealg resetting)  Allo  17,138 +  4,393  7,199 4- 3,143  445 4- 125  492 4- 195 
T  cell  enriched  (nylon  wool  ill-  Syn  1,334 4- 760  2,124 4- 1,333  1,226 ±  1,106  ND 
tered)  AIIo  6,091 ±  483  763 4- 103  275 ±  218  ND 
13,073 4- 2,292 
1,795 4- 994 
I 1,642 4- 1,722 
882 4- 620 
9,992 4- 1,553 
Experiment  1: E~-rosetted  T  cells and irradiated stimulator cells were cultured in round-bottomed wells. [~H]Thymidine uptake without stimulators 
was 600 4- 287 for Syn responders and 3228 4- 1746 for Allo responders. The DC-enriched fraction was 35% DC, 10% monocytes,  and 55% small cells. 
Experiment 2: Nylon T cells and irradiated stimulator cells were cultured in flat-bottomed wells. [3H]Thymidine uptake without stimulators was 638 
4- 464 for Syn responders, and 245 ±  132 for Allo responders. The DC-enriched fraction was 23% DC, 24% monocytes, and 53% small cells. 
* Not done. 
weak  or totally inactive  as stimulators.  We conclude that  human DC  are the most 
potent stimulating cells for both allogeneic and syngeneic MLR. It is possible that all 
other cell populations would be nonstimulatory if depleted of DC. 
Accessory  Cell  Function  in  Oxidative  Mitogenesis.  Human  T  cells,  modified  with 
periodate, will not proliferate unless irradiated accessory cells (not periodate modified) 
are added (32). The accessory cell activity of our different cell populations paralleled 
MLR-stimulating  capacity in most  experiments.  Again, DC-enriched fractions were 
the most  active accessory cells, and this was not reduced by B cell depletion  (Table 
IV,  experiment  2).  Monocyte-enriched  fractions  varied  in activity  (compare  experi- 
ments  1, 2, and 3, Table IV). In four out of five experiments,  monocyte populations 
were  10-30-fold  less active  than enriched  DC.  Monocytes did not inhibit DC when 
co-cultivated, unless added at high doses (20%, see Table IV, experiment 3). B and T 
cell fractions were again weak or inactive. We conclude that human DC, like rodent 
DG (2, 9), are potent accessory cells for the proliferation of periodate-modified T cells. 1182  ttUMAN  DENDRITIC  CELLS 
TABLE IV 
Ability of Subpopulations of Mononuclear Cells to Act as Accesso(y Cells  for Oxidative Mitogenesis 
Accessory cell population  Doses of irradiated accessory cells 
Experiment  l0  b  3 ×  10  4  10  4  3 ×  10  a 
DC enriched (without Ectlg ro-  108,024 ±  2,625  68,297 ±  6,811  34,30l  ±  1,890  13,796 ±  936 
setting) 
Monocyte enriched (firmly ad-  42,170 ±  27,057  46,162 ±  1,653  24,048 ±  1,958 
herent) 
Monocyte  enriched  (readher-  51,470 ±  2,353  39,427 ±  4,290  18,285 ±  1,183 
ent) 
B cell enriched  (without Ealg  2,180 ±  571  2,228 ±  886 
rosetting) 
T  cell enriched (En ÷)  ND*  5,245 ±  1,219 
Non-T ceils (En-)  15,384 ±  2,395  5,146 ±  718  3,145 ±  718 
Experiment 2  5 x  104  1.5 ×  104  5 ×  103  1.5 ×  10  a 
DC enriched (with Ectla roset-  84,518 ±  9,624  69,385 ±  1,714  44,854 ±  1,522  25,335 ±  3,840 
ting) 
DC enriched (without EctIg ro-  98,293 ±  8,348  66,560 ±  8,023  42,463 ±  1,091  27,402 ±  2,278 
setting) 
Monocyte enriched (firmly ad-  17,379 ±  2,385  8,485 ±  1,064  7,274 ±  840  4,961  ±  982 
herent) 
B cell enriched (with Et~Ig ro-  38,527 ±  6,498  18,831  ±  1,345  8,463 ±  1,603  5,809 ±  2,346 
setting) 
B cell enriched  (without  E~dg  5,743 ±  1,493  3,757 ±  236  2,536 +_ 865  3,69l  ±  1,162 
rosetting) 
T  cell enriched (nylon wool T)  7,801  ±  1,468  5,525 ±  1,215 
Experiment 3  3 ×  10  4  10  4  3 ×  10  a  10  3 
DC enriched (with Ealg roset-  63,691 ±  3,224  39,013 ±  4,010  19,977 ±  4,457  10,985 --- 1,724 
ting) 
Monocyte enriched (firmly ad-  5,966 ±  754  7,317 ±  904  4,610 ±  1,150  3,237 ±  214 
herent) 
DC-monocyte mixture:~  36,899 ±  754  36,320 ±  904  22,616 ±  1,150  9,484 ±  214 
B cell enriched (with EaIg ro-  19,438 ±  1,914  8,815 ±  1,866  5,218 ±  957  3,735 ±  744 
setting) 
T  cell enriched (nylon wool T)  4,779 +  683  4,215 ±  683 
Experiment  1:  F~-rosetted T  cells (+IO4)  and irradiated accessory cells were cultured in round-bottomed 
wells, and the same populations used as MLR stimulators in Table III experiment 1 were used as irradiated 
accessory cells. Proliferative response of T  ceils only (no 104) was 177 ±  59; T  cells only (+IO4) was 5,772 
±  3,935; and T  cells (no 104) +  105 DC enriched was 2,501 ±  380. 
Experiment 2: Nylon T  cells (+104) and irradiated accessory cells were cultured in fiat-bottomed wells. 
The twice-released fraction (see Table I) was divided in half and treated with bovine E or bovine E anti- 
human Ig, and floated in BPA. This produced two  DC-enriched fractions (low density)  and two B  cell 
fractions (high density). The DC-enriched fraction with E  anti-human Ig was 31%  DC, 45% monocytes, 
and 24%  small cells. The DC-enriched fraction without E  anti-human Ig was 28%  DC, 34% monocytes, 
and 38% small cells. Proliferative responses ofT  cells only (no IO4)  was 358 ±  157;  T  cells only (+  IO4) 
3,418 ±  754;  and for T  cells (no IO4)  +  5 ×  104 DC was 3,856 ±  810. 
Experiment 3: Nylon T  cells (+IO4) and irradiated accessory cells were cultured in fiat-bottomed wells. 
The DC-enriched fraction was 34% DC,  16% monocytes, and 50% small cells. Proliferative responses ofT 
cells only (no IO4)  was 2,584 +  485; T  cells only (+IO4) was 2,648 _-. 737;  and for T  cells (no 104)  +  3 × 
104 DC was 5, 231  ±  389. 
* Not done. 
:~ The DC-monoeyte mixture (1:1)  had 6  ×  104 total cells at the highest dose, 2 ×  104 cells at the next 
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Discussion 
Human blood mononuclear cells have a small subpopulation (0.1-0.5%) of DC that 
are virtually identical to DC in mouse and rats. Human DC were enriched to 20-60% 
purity and compared with enriched populations of monocytes, B cells, and T  cells by 
several  criteria.  First,  the  morphology  of  DC  is  distinctive.  DC  extend  smooth 
cytoplasmic processes in several directions, have irregularly shaped nuclei and many 
mitochondria, but exhibit few lysosomes or endocytic vacuoles. Second, DC express 
histocompatibility (HLA, HLA-DR)  and  leukocyte-common antigens,  but  lack the 
principle  differentiation  markers  of  monocytes  (phagocytic  capacity,  peroxidase, 
esterase,  Fc receptors, four surface antigens  detected with  monoclonal Ab),  B  cells 
(surface  and  intracellular  Ig),  and  T  cells  (E-rosette  receptor;  OKT  3,  6,  and  8 
antigens).  Third,  DC  are  at  least  10  times  more  active  than  other cells  as  MLR 
stimulators and as accessory cells for periodate-induced mitogenesis. 
A  clear  difference between  DC  of man  and  mouse  is  that  human  DC  express 
complement receptors, i.e., they rosette erythrocytes coated with IgM and fresh mouse 
serum. Complement receptors have not  been detected on mouse DC with the same 
reagent.  Conceivably this  difference is  related  to  the  species  or  tissue  studied,  the 
possibility  that  the  receptor in  mouse may be masked  or occupied by endogenous 
complement,  or  the  possibility  that  expression  of complement  receptors  may  be 
associated with an activation or differentiation step. 
This paper provides the first description of DC in the circulation. Circulating cells 
are likely to be part of a widely spread DC system. For example, we have found DC 
in human spleen and tonsil that are indistinguishable from blood DC in morphology, 
low bouyant density, and surface markers. In mice and rats, DC have been enriched 
from spleen  and  node  (2-5)  and  can  be detected in  thymus,  liver, and  peritoneal 
cavity  (33  and  R.  Steinman,  unpublished  observations).  Hart  and  Fabre  have 
visualized Ia-bearing DC in sections of all rat nonlymphoid tissues except brain (34). 
Mason et al.  (3)  have demonstrated a  substantial  flux (>106 cells/d)  of typical DC 
into the afferent lymph draining rat  intestine. These DC probably are identical to 
Langerhans  cells  in  the  afferent  lymph  of guinea  pigs  (35)  and  "veiled" cells  in 
afferent lymph of rabbits  (36).  DC in all sites  (lymph, lymphoid, and nonlymphoid 
organs) are bone marrow derived, bear Ia and leukocyte-common antigen, and lack 
the differentiation markers of macrophages and B cells (3, 5, 34, 37, 38). 
Relatively little is known about the kinetics and sites of DC production and their 
movement between different organs. Are all DC in tissues end-stage elements derived 
from proliferating bone marrow precursors? Can  DC recirculate from one compart- 
ment to another, or at least move continuously from tissues to lymphoid organs via 
afferent lymph? Can DC proliferate locally in tissues, or be elicited from the marrow 
in increased numbers during inflammatory responses? The behavior of DC in inflam- 
mation  is an  important  unknown, since entry of such potent  accessory cells into a 
lesion would intensify immune responses at the local level. For example, cells resem- 
bling  DC  have  been  described  in  synovial  tissue  from  patients  with  rheumatoid 
arthritis  (39,  40).  In preliminary experiments on rheumatoid synovial exudates, we 
have found relatively large numbers of cells that have the same cytologic features and 
surface markers as blood DC. 
There are  difficulties with  the  study of DC  from  human  blood compared with 
mouse spleen. First, it is difficult to study DC in fresh, adherent blood mononuclear 1184  HUMAN  DENDRITIC  CELLS 
cells because they are far outnumbered by B cells and monocytes. In contrast, mouse 
spleen adherent cells contain 10-50% DC. Second, human DC cannot be significantly 
enriched by density gradient  separation  of fresh blood mononuclear cells, because 
almost all monocytes are of low density as well. Mouse splenic DC are enriched by 
this technique because most splenic macrophages are of high density. Third, human 
DC cannot be enriched to the same degree of purity as mouse (>90%). The majority 
of the  contaminating  cells  aresmall,  Ia-bearing  cells,  which  lack  differentiation 
markers of B cells, T cells, and monocytes and do not differentate into these in culture. 
We have assumed, because of analogy to the rat and mouse, that the cells with the 
cytologic characteristics of DC  account  for the  functional activity of DC-enriched 
fractions, but small, Ia-bearing cells may also contribute. Fourth, it is more difficult 
to deplete DC from human monocyte and lymphocyte fractions. Monocyte-enriched 
fractions contained 1-6% DC, B cells enriched with anti-Ig rosetting contained 1-4% 
DC, and non-T cells contained 2-10% DC. These levels of DC contamination could 
account for the variable functional activity of these populations. 
We  propose that  DC  are  the  principal  MLR  stimulators  and  accessory cells  in 
human blood mononuclear cells, because DC fractions are much more potent than 
other fractions and  because the small  numbers of DC  in  the other fractions could 
explain their activity. Reagents that would selectively deplete human DC are needed 
to pursue this hypothesis. In mouse, a  DC-specific cytotoxic monoclonal Ab ablates 
MLR-stimulating activity from mouse spleen (12). "It is hoped that the DC-enriched 
populations described in this paper will be useful, as in the mouse, to immunize and 
screen for human DC-specific monoclonal Ab. 
Summary 
Previous studies demonstrated that lymphoid tissues of mice and rats contain small 
numbers  (<1%  of nucleated  cells)  of dendritic  cells  (DC)  with  special  cytologic, 
surface, and functional properties. We show here that similar DC represent 0.1-0.5% 
of human peripheral blood mononuclear cells.  DC can be enriched to 20-60% purity 
by a multistep procedure analogous to that used in mice. Adherent peripheral blood 
mononuclear  cells  are  cultured  overnight,  and  the  released  cells  are  depleted  of 
monocytes and B cells by readherence to plastic, rosetting With erythrocytes coated 
with anti-human  IgG, and centrifugation in dense albumin columns.  Enriched DC 
have similar cytologic features to rodent DC by light and electron microscopy. 
DC express HLA, and HLA-DR and the leukocyte-common antigens.  They lack 
phagocytic capacity, receptors for antibody-coated and neuraminidase-treated eryth- 
rocytes, surface and  intracellular Ig, esterase, peroxidase, and  azurophilic granules. 
DC do not react with several monoclonal antibodies directed to phagocytes (OKM 1, 
"mac-l," 63D3, and 61D3) and T  cells (OKT 3, 6, 8). Unlike the mouse, human DC 
express complement receptors. When maintained in culture for 4 d, human DC did 
not  give rise to either B  cells or monocytes. Therefore, DC  identified by cytologic 
criteria are distinct from other leukocytes. 
Enriched populations of DC have been compared to fractions enriched in mono- 
cytes,  B  cells,  and  T  cells  in  three  functional  assays:  stimulation  of the  primary 
allogeneic mixed leukocyte reaction, stimulation of the primary syngeneic MLR, and 
accessory function for the proliferation of periodate-modified T  cells. In each case, the 
DC fraction was  10-fold or more active than other cell fractions. We conclude that VAN VOORHIS,  HAIR,  STEINMAN, AND KAPLAN  1185 
DC circulate in man, and represent the principal cell type required for the initiation 
of several immune responses. 
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